Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peter van Tintelen

Showing results (101-110 of 232) with videos related to

Pageof 24
Sort By:
Scientific Reports|March 13, 2019
Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated CardiomyopathyOyediran Akinrinade, Tiina Heliö, Ronald H Lekanne Deprez, et al.
Scientific Reports|October 10, 2020
Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated CardiomyopathyOyediran Akinrinade, Tiina Heliö, Ronald H Lekanne Deprez, et al.
Journal of the American College of Cardiology|February 4, 2017
Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular TachycardiaJeroen Venlet, Sebastiaan R D Piers, Jan D H Jongbloed, et al.
Heart Rhythm|November 12, 2021
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiogramsRemco de Brouwer, Laura M G Meems, Tom E Verstraelen, et al.
European Heart Journal|April 8, 2015
The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human GeneticsJens Mogensen, J Peter van Tintelen, Siv Fokstuen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|August 1, 2017
Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathyWouter P Te Rijdt, Z Joy van der Klooster, Edgar T Hoorntje, et al.
Journal of Cardiovascular Electrophysiology|December 3, 2024
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and ManagementSteven A Muller, Giorgia Bertoli, Jianan Wang, et al.
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular CardiomyopathyLaurens P Bosman, Weijia Wang, Øyvind H Lie, et al.
Journal of the American College of Cardiology|November 26, 2011
Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural historyEline A Nannenberg, Michelle Michels, Imke Christiaans, et al.
JAMA Cardiology|April 30, 2025
Cardiomyopathy-Associated Gene Variants in Atrial FibrillationLeonoor F J M Wijdeveld, Ezimamaka Ajufo, Saketh P Challa, et al.
Pageof 24

Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
Scientific Reports|March 13, 2019
Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated CardiomyopathyOyediran Akinrinade, Tiina Heliö, Ronald H Lekanne Deprez, et al.
Scientific Reports|October 10, 2020
Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated CardiomyopathyOyediran Akinrinade, Tiina Heliö, Ronald H Lekanne Deprez, et al.
Journal of the American College of Cardiology|February 4, 2017
Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular TachycardiaJeroen Venlet, Sebastiaan R D Piers, Jan D H Jongbloed, et al.
Heart Rhythm|November 12, 2021
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiogramsRemco de Brouwer, Laura M G Meems, Tom E Verstraelen, et al.
European Heart Journal|April 8, 2015
The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human GeneticsJens Mogensen, J Peter van Tintelen, Siv Fokstuen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|August 1, 2017
Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathyWouter P Te Rijdt, Z Joy van der Klooster, Edgar T Hoorntje, et al.
Journal of Cardiovascular Electrophysiology|December 3, 2024
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and ManagementSteven A Muller, Giorgia Bertoli, Jianan Wang, et al.
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular CardiomyopathyLaurens P Bosman, Weijia Wang, Øyvind H Lie, et al.
Journal of the American College of Cardiology|November 26, 2011
Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural historyEline A Nannenberg, Michelle Michels, Imke Christiaans, et al.
JAMA Cardiology|April 30, 2025
Cardiomyopathy-Associated Gene Variants in Atrial FibrillationLeonoor F J M Wijdeveld, Ezimamaka Ajufo, Saketh P Challa, et al.
Pageof 24